Last reviewed · How we verify
NCT04552574
Randomized Clinical Trial of HMR(Home Meal Replacement)-Type Omega-3-balanced-diet
NA trial testing HMR(Home meal replacement)-type omega-3-balanced diet in Chronic Metabolic Disorder in 76 participants. Status unknown.
31 December 2021
Quick facts
| Lead sponsor | Chungbuk National University Hospital |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 76 |
| Start date | 19 August 2020 |
| Primary completion | 31 December 2021 |
| Estimated completion | 31 December 2021 |
| Sites | 1 location across South Korea |
Drugs / interventions tested
- HMR(Home meal replacement)-type omega-3-balanced diet
Conditions studied
- Chronic Metabolic Disorder — all drugs for Chronic Metabolic Disorder →
- Lipid Metabolism Disorders — all drugs for Lipid Metabolism Disorders →
- Sarcopenia — all drugs for Sarcopenia →
Sponsor
Chungbuk National University Hospital
Who can join
40 and older, any sex, with Chronic Metabolic Disorder or Lipid Metabolism Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Investigate whether HMR(Home meal replacement)-type omega-3-balanced-diet can improve clinical laboratory values related to chronic metabolic diseases through reducing lipids and chronic inflammation, and can prevent muscle loss.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Beneficial Effects of a Specially Designed Home Meal Replacement on Cardiometabolic Parameters in Individuals with Obesity: Preliminary Results of a Randomized Controlled Clinical Trial.
Lee JW, Kim Y, Hyun T, Song S, et al · · 2021 · cited 5× · PMID 34202690 · DOI 10.3390/nu13072171
Verify or expand the search:
- PubMed search for NCT04552574
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Chungbuk National University Hospital trials
Trials by the same sponsor.
- NCT07037303 — Comparing Active Cycle of Breathing Techniques (ACBT) and Aerobika in Treating Bronchiectasis in Korea · NA · not yet recruiting
- NCT05994547 — Efficacy and Safety of Remimazolam Compared With Midazolam During Bronchoscopy:Randomised Controlled Trial · Phase 4 · completed
- NCT04893148 — Efficacy and Safety of iGlarLixi Versus Insulin Glargine Plus Dulaglutide in Patients With Type 2 Diabetes · Phase 4 · unknown
- NCT04647838 — Tepotinib in Solid Tumors Harboring MET Alterations · Phase 2 · unknown
- NCT03473262 — Empagliflozin-based Quadruple Combination vs Insulin Glarine-based Combination Therapy in Patients With Type 2 Diabetes · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04552574 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Chungbuk National University Hospital
- Last refreshed: 22 September 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04552574.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing